Castagna L, Nozza A, Bertuzzi A, Siracusano L, Timofeeva I, Santoro A
Department of Medical Oncology and Hematology, Instituto Clinico Humanitas, 56 via Manzoni, 20089 Rozzano, Milan, Italy.
Bone Marrow Transplant. 2001 Dec;28(12):1155-6. doi: 10.1038/sj.bmt.1703309.
A patient with progressive prolymphocytic leukemia (PLL) received an allogeneic stem cell transplant using a reduced intensity conditioning regimen to avoid prohibitive toxicities. Early in the post-transplant period, a high donor-derived CD8+ count was observed. One year from transplantation, the patient was in complete remission, fully donor chimeric and with a normal performance status, suggesting that this approach may represent a useful treatment option in patients with refractory PLL.
一名进行性原淋巴细胞白血病(PLL)患者接受了异基因干细胞移植,采用减低强度预处理方案以避免严重毒性。在移植后早期,观察到供体来源的CD8+计数较高。移植后一年,患者完全缓解,完全为供体嵌合状态且体能状态正常,这表明该方法可能是难治性PLL患者的一种有效治疗选择。